Search Results - "Maddock, Helen"

Refine Results
  1. 1

    Attenuation of doxorubicin-induced cardiotoxicity by mdivi-1: a mitochondrial division/mitophagy inhibitor by Gharanei, Mayel, Hussain, Afthab, Janneh, Omar, Maddock, Helen

    Published in PloS one (17-10-2013)
    “…Doxorubicin is one of the most effective anti-cancer agents. However, its use is associated with adverse cardiac effects, including cardiomyopathy and…”
    Get full text
    Journal Article
  2. 2

    Development of a novel low-order model for atrial function and a study of atrial mechano-electric feedback by Pearce, Nicholas F., Turner, Mark C., Maddock, Helen L., Kim, Eun-jin

    Published in Computers in biology and medicine (01-06-2023)
    “…Numerical models of the cardiovascular system have largely focused on the function of the ventricles, with atrial function often neglected. Furthermore, the…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Anti-cancer Therapy Leads to Increased Cardiovascular Susceptibility to COVID-19 by Lozahic, Caroline, Maddock, Helen, Sandhu, Hardip

    Published in Frontiers in cardiovascular medicine (23-04-2021)
    “…Anti-cancer treatment regimens can lead to both acute- and long-term myocardial injury due to off-target effects. Besides, cancer patients and survivors are…”
    Get full text
    Journal Article
  5. 5

    Predictivity of in vitro non-clinical cardiac contractility assays for inotropic effects in humans — A literature search by Wallis, Rob, Gharanei, Mayel, Maddock, Helen

    “…Adverse drug effects on the cardiovascular system are a major cause of compound attrition throughout compound discovery and development. There are many ways by…”
    Get full text
    Journal Article
  6. 6

    Caspase Inhibition Via A3 Adenosine Receptors: A New Cardioprotective Mechanism Against Myocardial Infarction by Hussain, Afthab, Gharanei, Ahmed Mayel, Nagra, Aarondeep Singh, Maddock, Helen L.

    Published in Cardiovascular drugs and therapy (01-02-2014)
    “…Purpose 2-CL-IB-MECA, (A 3 adenosine receptor agonist)(A 3 AR) mediated cardioprotection is well documented although the associated intracellular signalling…”
    Get full text
    Journal Article
  7. 7

    Ipratropium bromide-mediated myocardial injury in in vitro models of myocardial ischaemia/reperfusion by Harvey, Kate L, Hussain, Afthab, Maddock, Helen L

    Published in Toxicological sciences (01-04-2014)
    “…Ipratropium bromide, a nonselective muscarinic antagonist, is widely prescribed for the treatment of chronic obstructive pulmonary disease (COPD). Analyses of…”
    Get full text
    Journal Article
  8. 8

    Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? by HAUSENLOY, Derek J, MADDOCK, Helen L, BAXTER, Gary F, YELLON, Derek M

    Published in Cardiovascular research (15-08-2002)
    “…We propose that ischemic preconditioning (IPC) and mitochondrial K(ATP) channel activation protect the myocardium by inhibiting mitochondrial permeability…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Validity and reliability of short‐term heart‐rate variability from disposable electrocardiography leads by Okwose, Nduka C., Russell, Sophie L., Rahman, Mushidur, Steward, Charles J., Harwood, Amy E., McGregor, Gordon, Ninkovic, Srdjan, Maddock, Helen, Banerjee, Prithwish, Jakovljevic, Djordje G.

    Published in Health science reports (01-01-2023)
    “…Background and Aims Single‐use electrocardiography (ECG) leads have been developed to reduce healthcare‐associated infection. This study compared the validity…”
    Get full text
    Journal Article
  11. 11

    Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide by MOCANU, Mihaela M, MADDOCK, Helen L, BAXTER, Gary F, LAWRENCE, Christina L, STANDEN, Nicholas B, YELLON, Derek M

    Published in Circulation (New York, N.Y.) (26-06-2001)
    “…The sulfonylurea glibenclamide (Glib) abolishes the cardioprotective effect of ischemic preconditioning (IP), presumably by inhibiting mitochondrial K(ATP)…”
    Get full text
    Journal Article
  12. 12

    The cardioprotective and mitochondrial depolarising properties of exogenous nitric oxide in mouse heart by BELL, Robert M, MADDOCK, Helen L, YELLON, Derek M

    Published in Cardiovascular research (01-02-2003)
    “…Nitric oxide (NO) is reported to be both protective and detrimental in models of myocardial ischaemia/reperfusion injury, which may be concentration dependent…”
    Get full text
    Journal Article
  13. 13

    Molecular basis of cancer-therapy-induced cardiotoxicity: introducing microRNA biomarkers for early assessment of subclinical myocardial injury by Sandhu, Hardip, Maddock, Helen

    Published in Clinical science (1979) (01-03-2014)
    “…Development of reliable biomarkers for early clinical assessment of drug-induced cardiotoxicity could allow the detection of subclinical cardiac injury risk in…”
    Get more information
    Journal Article
  14. 14

    Myocardial Fatigue: a Mechano-energetic Concept in Heart Failure by Tran, Patrick, Maddock, Helen, Banerjee, Prithwish

    Published in Current cardiology reports (01-06-2022)
    “…Purpose of Review This review combines existing mechano-energetic principles to provide a refreshing perspective in heart failure (HF) and examine if the…”
    Get full text
    Journal Article
  15. 15

    Protection from myocardial stunning by ischaemia and hypoxia with the adenosine A3 receptor agonist, IB-MECA by MADDOCK, Helen L, GARDNER, Neil M, KHANDOUDI, Nassirah, BRIL, Antoine, BROADLEY, Kenneth J

    Published in European journal of pharmacology (23-09-2003)
    “…Guinea pig isolated working hearts were exposed to 30-min ischaemia by reducing coronary flow to 10%, followed by reperfusion. Aortic output fell to 4.5+/-4.5%…”
    Get full text
    Journal Article
  16. 16

    Myocardial protection from either ischaemic preconditioning or nicorandil is not blocked by gliclazide by MADDOCK, Helen L, SIEDLECKA, Sylvia M, YELLON, Derek M

    Published in Cardiovascular drugs and therapy (01-03-2004)
    “…We compared the effects of two sulphonylureas, glibenclamide and gliclazide, on ischaemic preconditioning (IPC) and nicorandil-induced protection in the…”
    Get full text
    Journal Article
  17. 17

    Doxorubicin alters G-protein coupled receptor-mediated vasocontraction in rat coronary arteries by Lozahic, Caroline, Maddock, Helen, Wheatley, Mark, Sandhu, Hardip

    “…Doxorubicin (Doxo)-associated cardio-and vasotoxicity has been recognised as a serious complication of cancer chemotherapy. The purpose of this novel paper was…”
    Get full text
    Journal Article
  18. 18

    Effects of hydrogen sulphide on the isolated perfused rat heart by Maddock, Helen, al-Rajaibi, Hajir, Carson, Ray J., Husayn, Afthab

    Published in Sultan Qaboos University medical journal (01-05-2011)
    “…Objectives : Hydrogen supplied has been identified as a gas signaling molecule in the body, and has previously been shown to have vasorelaxant properties. The…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Metformin Protects Against Sunitinib-induced Cardiotoxicity: Investigating the Role of AMPK by Kuburas, Refik, Gharanei, Mayel, Haussmann, Irmgard, Maddock, Helen, Sandhu, Hardip

    Published in Journal of cardiovascular pharmacology (01-06-2022)
    “…Sunitinib is associated with cardiotoxicity through inhibition of AMP-protein kinase (AMPK) signaling. By contrast, the common antidiabetic agent metformin has…”
    Get full text
    Journal Article